Covered recipient · General Payments record
JOLENE MARIE KIM
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,715.78
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $450.32 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $167.40 | 11 |
| Amgen Inc. | $72.61 | 5 |
| DEXCOM, INC. | $53.32 | 3 |
| PFIZER INC. | $45.20 | 3 |
| Novo Nordisk AS | $35.09 | 2 |
| ABBVIE INC. | $33.58 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $28.63 | 1 |
| GlaxoSmithKline, LLC. | $14.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.48 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104073758 | CMS |
| ABBVIE INC. | $13.10 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104073760 | CMS |
| Amgen Inc. | $16.67 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297466 | CMS |
| Amgen Inc. | $13.68 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620142 | CMS |
| Amgen Inc. | $14.93 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297468 | CMS |
| Amgen Inc. | $13.15 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297470 | CMS |
| Amgen Inc. | $14.18 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297472 | CMS |
| Boston Scientific Corporation | $28.63 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092579303 | CMS |
| Dexcom, Inc. | $20.00 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153310435 | CMS |
| Dexcom, Inc. | $19.60 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153310437 | CMS |
| Dexcom, Inc. | $13.72 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153310439 | CMS |
| GlaxoSmithKline, LLC. | $14.49 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116301968 | CMS |
| Lilly USA, LLC | $21.79 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135062547 | CMS |
| Lilly USA, LLC | $9.90 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135061079 | CMS |
| Lilly USA, LLC | $13.79 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135061077 | CMS |
| Lilly USA, LLC | $15.22 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135062549 | CMS |
| Lilly USA, LLC | $10.33 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135092885 | CMS |
| Lilly USA, LLC | $12.65 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135071589 | CMS |
| Lilly USA, LLC | $15.39 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135071591 | CMS |
| Lilly USA, LLC | $16.60 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135062551 | CMS |
| Lilly USA, LLC | $19.25 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135071585 | CMS |
| Lilly USA, LLC | $16.74 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135071587 | CMS |
| Lilly USA, LLC | $15.74 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135085884 | CMS |
| Novo Nordisk Inc | $18.16 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097515927 | CMS |
| Novo Nordisk Inc | $16.93 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096997823 | CMS |
| PFIZER INC. | $15.04 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130937743 | CMS |
| PFIZER INC. | $15.14 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130945242 | CMS |
| PFIZER INC. | $15.02 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131181556 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.